Mouth Ulcer Treatment Market Research Report – Forecast to 2023

Mouth Ulcer Treatment Market Research Report – Forecast to 2023

ID: MRFR/HC/4960-HCRR | October, 2018 | Region: Global | 90 pages | Half-Cooked Research Reports

Global Mouth Ulcer Treatment Market Research Report: By Drug Type (Corticosteroid, Antihistamine, Antimicrobial, Analgesic, & Others), by Formulations (Gel, Mouthwash, Spray, & Others), by Indication (Aphthous Stomatitis, and Others) – Forecast Till 2023


Market Scenario


The global mouth ulcer treatment market is expected to grow significantly over the forecast period. It is estimated that the mouth ulcer treatment market is expected to register a CAGR of ~ 4 % during the forecast period from 2018 to 2023.


Mouth ulcers are painful sores that can develop in the mucous membrane of the oral cavity and this restrict the ability to chew, bite or eat. Some factors which result in mouth ulcer are stress, infection, injury, allergy, and others which leads to intense pain. Increasing use of synthetics in oral items such as toothpaste and growing unhealthy lifestyle, including high consumption of junk food and tobacco are some of the factors driving the growth of this market. Mouth ulcer can be prevented by avoiding tissue injury, avoiding the food that causes irritation in mouth and maintaining oral hygiene. Besides the traditional method, various drugs are used to treat mouth ulcer. Increasing aging population and increasing incidences of mouth ulcer are driving the growth of this market.


However, people have a very casual approach towards mouth ulcer, which can lead to negative impact on the growth of the market in future.  


Segmentation


The global mouth ulcer treatment market has been segmented on basis of drug type, formulation, and indication. On basis of drug type, the market is segmented into corticosteroid, antihistamine, antimicrobial, analgesic, and anesthetic. Based on formulation, the mouth ulcer treatment market is segmented into gel, mouthwash, ointment, spray, and lozenges. Based on indication mouth ulcer treatment market is segmented into Aphthous Stomatitis, Oral Lichen Planus and Others.


Key players


Key players in the mouth ulcer treatment market are Pfizer, Inc., Church & Dwight Co., Inc., 3M, Taro Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, BLISTEX, INC., GlaxoSmithKline plc.,


ECR Pharmaceuticals, Sannova, Reckitt Benckiser, Sunstar, Blairex Laboratories, Sanjin Pharmaceutical, Joincare Pharmaceutical, Sinclair Pharma, Colgate-Palmolive Company


Regional Market Summary


Global Mouth Ulcer Treatment Market Share (%), by Region, 2018


Mouth Ulcer Treatment Market Share


Source: World Health Organization (WHO)


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The mouth ulcer treatment market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European mouth ulcer treatment market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The mouth ulcer treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The mouth ulcer treatment market in the Middle East and Africa has been segmented into the Middle East and Africa.


On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and the Middle East and Africa. North America market is anticipated to dominate the mouth ulcer treatment market due to advanced technology made in diagnostic procedures of oral and dental care. Growing awareness among consumers regarding the availability of mouth ulcer treatment is the key share to increase the growth of the market in North America. Europe is anticipated to drive the growth of mouth ulcer treatment in upcoming years due to increasing incidences of an aging population suffering from mouth ulcer. Asia-Pacific is projected to register a robust growth due to increasing initiatives of government regarding mouth ulcer and increasing patients with mouth ulcer cases. The Middle East and Africa is expected to account for the lowest market share in the global mouth ulcer treatment market due to lack of advanced technology and poor medical facilities in developing economies in this region.


Global Mouth Ulcer Treatment Market, by Drug Type



  • Corticosteroid

  • Antihistamine

  • Antimicrobial

  • Analgesic

  • Anesthetic


Global Mouth Ulcer Treatment Market, by Formulation



  • Gel

  • Mouthwash

  • Ointment

  • Spray

  • Lozenges


Global Mouth Ulcer Treatment Market, by Indications



  • Aphthous Stomatitis

  • Oral Lichen Planus

  • Others


Global Mouth Ulcer Treatment Market, by Region



  • Americas



  • North America

  • US

  • Canada

  • South America



  • Europe



  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe



  • Asia-Pacific



  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific



  • Middle East & Africa



  • Middle East

  • Africa

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Mouth Ulcer Treatment Market, by Drug Type

6.1 Introduction

6.2 Corticosteroid

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3 Antihistamine

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.4 Antimicrobial

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.5 Analgesic

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.6 Anesthetic

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 7. Global Mouth Ulcer Treatment Market, by Formulation

7.1 Introduction

7.2 Gel

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3 Mouthwash

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.4 Ointment

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.5 Spray

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.6 Lozenges

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 8. Global Mouth Ulcer Treatment Market, by Indications

8.1 Introduction

8.2 Aphthous Stomatitis

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–202

8.3 Oral Lichen Planus

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.4 Others

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023



Chapter 9. Global Cosmetic Dentistry, by Region

9.1 Introduction

9.2 America

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Pfizer, Inc.

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Church & Dwight Co., Inc

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 3M, Taro Pharmaceutical Industries Ltd

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Bristol-Myers Squibb Company

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 BLISTEX, INC

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 GlaxoSmithKline plc

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 ECR Pharmaceuticals

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11. 8 Sannova

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11. 9 Reckitt Benckiser

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Sunstar

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Blairex Laboratories

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.12 Sanjin Pharmaceutical

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11. 13 Joincare Pharmaceutical

11. 13.1Overview

11. 13.2Product Overview

11. 13.3Financials

11. 13.4Key Developments

11. 13.5SWOT Analysis

11. 14 Sinclair Pharma

11. 14.1Overview

11. 14.2Product Overview

11. 14.3Financials

11. 14.4Key Developments

11. 14.5SWOT Analysis

11. 15 Colgate-Palmolive Company

11. 15.1Overview

11. 15.2Product Overview

11. 15.3Financials

11. 15.4Key Developments

11. 15.5SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Global Mouth Ulcer Treatment Industry

Chapter 13. Appendix



LIST OF TABLES

Table 1 Global Mouth Ulcer Treatment Market Synopsis, 2018–2023

Table 2 Global Mouth Ulcer Treatment Market Estimates and Forecast, 2018–2023 (USD Million)

Table 3 Global Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)

Table 4 Global Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)

Table 5 Global Mouth Ulcer Treatment Market, by Indications, 2018–2023 (USD Million)

Table 6 Global Mouth Ulcer Treatment Market, by Region, 2018–2023(USD Million)

Table 7 North America: Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)

Table 8 North America: Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)

Table 9 North America: Mouth Ulcer Treatment Market, by Indication, 2018–2023 (USD Million)

Table 10 North America: Mouth Ulcer Treatment Market, by Region, 2018–2023 (USD Million)

Table 8 US: Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)

Table 11 US: Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)

Table 12 US: Mouth Ulcer Treatment Market, by Indication, 2018–2023 (USD Million)

Table 13 US: Mouth Ulcer Treatment Market, by Region, 2018–2023 (USD Million)

Table 13 Canada: Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)

Table 14 Canada: Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)

Table 17 Canada: Mouth Ulcer Treatment Market, by Indication, 2018–2023 (USD Million)

Table 15 Canada: Mouth Ulcer Treatment Market, by Region, 2018–2023 (USD Million)

Table 19 South America: Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)

Table 20 South America: Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)

Table 21 South America: Mouth Ulcer Treatment Market, by Indication, 2018–2023 (USD Million)

Table 22 South America: Mouth Ulcer Treatment Market, by Region, 2018–2023 (USD Million)

Table 23 Europe: Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)

Table 24 Europe: Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)

Table 25 Europe: Mouth Ulcer Treatment Market, by Indication, 2018–2023 (USD Million)

Table 26 Europe: Mouth Ulcer Treatment Market, by Region, 2018–2023 (USD Million)

Table 27 Western Europe: Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)

Table 28 Western Europe: Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)

Table 29 Western Europe: Mouth Ulcer Treatment Market, by Indication, 2018–2023 (USD Million)

Table 30 Western Europe: Mouth Ulcer Treatment Market, by Region, 2018–2023 (USD Million)

Table 31 Eastern Europe: Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)

Table 32 Eastern Europe: Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)

Table 33 Eastern Europe: Mouth Ulcer Treatment Market, by Indication, 2018–2023 (USD Million)

Table 34 Eastern Europe: Mouth Ulcer Treatment Market, by Region, 2018–2023 (USD Million)

Table 35 Asia-Pacific: Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)

Table 36 Asia-Pacific: Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)

Table 37 Asia-Pacific: Mouth Ulcer Treatment Market, by Indication, 2018–2023 (USD Million)

Table 38 Asia-Pacific: Mouth Ulcer Treatment Market, by Region, 2018–2023 (USD Million)

Table 39 Middle East & Africa: Mouth Ulcer Treatment Market, by Drug Type, 2018–2023 (USD Million)

Table 40 Middle East & Africa: Mouth Ulcer Treatment Market, by Formulation, 2018–2023 (USD Million)

Table 41 Middle East & Africa: Mouth Ulcer Treatment Market, by Indication, 2018–2023 (USD Million)

Table 42 Middle East & Africa: Mouth Ulcer Treatment Market, by Region, 2018–2023 (USD Million)





LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Mouth Ulcer Treatment Market

Figure 3 Segmentation Market Dynamics for Global Mouth Ulcer Treatment Market

Figure 4 Global Mouth Ulcer Treatment Market Share, by Drug Type, 2018(%)

Figure 5 Global Mouth Ulcer Treatment Market Share, by Formulation, 2018(%)

Figure 6 Global Mouth Ulcer Treatment Market Share, by Indications, 2018(%)

Figure 7 Global Mouth Ulcer Treatment Market Share, by Region, 2018(%)

Figure 8 North America: Mouth Ulcer Treatment Market Share, by Country, 2018(%)

Figure 9 Europe: Mouth Ulcer Treatment Market Share, by Country, 2018(%)

Figure 10 Asia-Pacific: Mouth Ulcer Treatment Market Share, by Country, 2018(%)

Figure 11 Middle East & Africa: Mouth Ulcer Treatment Market Share, by Country, 2018(%)

Figure 12 Global Mouth Ulcer Treatment Market: Company Share Analysis, 2018(%)

Figure 13 Pfizer, Inc: Key Financials

Figure 14 Pfizer, Inc: Segmental Revenue

Figure 15 Pfizer, Inc: Geographical Revenue

Figure 16 Church & Dwight Co., Inc: Key Financials

Figure 17 Church & Dwight Co., Inc: Segmental Revenue

Figure 18 Church & Dwight Co., Inc: Geographical Revenue

Figure 19 3M, Taro Pharmaceutical Industries Ltd: Key Financials

Figure 20 3M, Taro Pharmaceutical Industries Ltd: Segmental Revenue

Figure 21 3M, Taro Pharmaceutical Industries Ltd: Geographical Revenue

Figure 22 Bristol-Myers Squibb Company: Key Financials

Figure 23 Bristol-Myers Squibb Company: Segmental Revenue

Figure 24 Bristol-Myers Squibb Company: Geographical Revenue

Figure 25 BLISTEX, INC.: Key Financials

Figure 26 BLISTEX, INC.: Segmental Revenue

Figure 27 BLISTEX, INC.: Geographical Revenue

Figure 28 GlaxoSmithKline plc.: Key Financials

Figure 29 GlaxoSmithKline plc.: Segmental Revenue

Figure 30 GlaxoSmithKline plc.: Geographical Revenue

Figure 31 ECR Pharmaceuticals: Key Financials

Figure 32 ECR Pharmaceuticals: Segmental Revenue

Figure 33 ECR Pharmaceuticals: Geographical Revenue

Figure 34 Sannova: Key Financials

Figure 35 Sannova: Segmental Revenue

Figure 36 Sannova: Geographical Revenue

Figure 37 Reckitt Benckiser: Key Financials

Figure 38 Reckitt Benckiser: Segmental Revenue

Figure 39 Reckitt Benckiser: Geographical Revenue

Figure 40 Sunstar: Key Financials

Figure 41 Sunstar: Segmental Revenue

Figure 42 Sunstar: Geographical Revenue

Figure 43 Blairex Laboratories: Key Financials

Figure 44 Blairex Laboratories: Segmental Revenue

Figure 45 Blairex Laboratories: Geographical Revenue

Figure 46 Sanjin Pharmaceutical: Key Financials

Figure 47 Sanjin Pharmaceutical: Segmental Revenue

Figure 48 Sanjin Pharmaceutical: Geographical Revenue

Figure 49 Joincare Pharmaceutical.: Key Financials

Figure 50 Joincare Pharmaceutical.: Segmental Revenue

Figure 51 Joincare Pharmaceutical.: Geographical Revenue

Figure 52 Sinclair Pharma: Key Financials

Figure 53 Sinclair Pharma: Segmental Revenue

Figure 54 Sinclair Pharma: Geographical Revenue

Figure 55 Colgate-Palmolive Company: Key Financials

Figure 56 Colgate-Palmolive Company: Segmental Revenue

Figure 57 Colgate-Palmolive Company: Geographical Revenue